AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 105 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,394,000 | +3387.3% | 290,416 | +1522.4% | 0.04% | +3600.0% |
| Q4 2021 | $126,000 | -84.3% | 17,900 | -67.2% | 0.00% | -90.9% |
| Q2 2020 | $804,000 | -81.5% | 54,512 | -69.7% | 0.01% | -89.6% |
| Q4 2019 | $4,354,000 | +157.6% | 180,148 | +104.9% | 0.11% | +112.0% |
| Q3 2019 | $1,690,000 | +194.4% | 87,900 | +644.9% | 0.05% | -3.8% |
| Q3 2017 | $574,000 | +68.8% | 11,801 | +57.4% | 0.05% | +52.9% |
| Q1 2017 | $340,000 | -78.4% | 7,498 | -82.0% | 0.03% | -83.3% |
| Q4 2016 | $1,575,000 | +79.6% | 41,594 | +79.0% | 0.20% | +36.9% |
| Q3 2016 | $877,000 | +315.6% | 23,231 | +93.8% | 0.15% | +217.0% |
| Q2 2016 | $211,000 | – | 11,990 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |